Literature DB >> 31212021

The multifaceted role of mesenchymal stem cells in cancer.

Michael Timaner1, Kelvin K Tsai2, Yuval Shaked3.   

Abstract

Mesenchymal stem cells (MSCs) are multipotent stem cells derived from the mesoderm that give rise to several mesenchymal lineages, including osteoblasts, adipocytes, chondrocytes and myocytes. Their potent ability to home to tumors coupled with their differentiation potential and immunosuppressive function positions MSCs as key regulators of tumor fate. Here we review the existing knowledge on the involvement of MSCs in multiple tumor-promoting processes, including angiogenesis, epithelial-mesenchymal transition, metastasis, immunosuppression and therapy resistance. We also discuss the clinical potential of MSC-based therapy for cancer.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Angiogenesis; Immunosuppression; Mesenchymal stem cells; Metastasis; Resistance

Mesh:

Year:  2019        PMID: 31212021     DOI: 10.1016/j.semcancer.2019.06.003

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  37 in total

Review 1.  Molecular insights into the interplay between adiposity, breast cancer and bone metastasis.

Authors:  Sneha Soni; Meaghan Torvund; Chandi C Mandal
Journal:  Clin Exp Metastasis       Date:  2021-02-16       Impact factor: 5.150

Review 2.  Administration of mesenchymal stem cells in diabetic kidney disease: mechanisms, signaling pathways, and preclinical evidence.

Authors:  Yuexin Zhu; Manyu Luo; Xue Bai; Yan Lou; Ping Nie; Shan Jiang; Jicui Li; Bing Li; Ping Luo
Journal:  Mol Cell Biochem       Date:  2022-04-25       Impact factor: 3.396

3.  Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.

Authors:  Sanjukta Chakraborty; Michelle Carnazza; Tara Jarboe; Nicole DeSouza; Xiu-Min Li; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Mesenchymal stem cells-based therapy in liver diseases.

Authors:  Heng-Tong Han; Wei-Lin Jin; Xun Li
Journal:  Mol Biomed       Date:  2022-07-27

Review 5.  EndMT-derived mesenchymal stem cells: a new therapeutic target to atherosclerosis treatment.

Authors:  Xiaofan Zhang; Zhong Ren; Zhisheng Jiang
Journal:  Mol Cell Biochem       Date:  2022-09-09       Impact factor: 3.842

Review 6.  Mitochondria: emerging therapeutic strategies for oocyte rescue.

Authors:  Zhixin Jiang; Huan Shen
Journal:  Reprod Sci       Date:  2021-03-12       Impact factor: 3.060

7.  Let-7f miRNA regulates SDF-1α- and hypoxia-promoted migration of mesenchymal stem cells and attenuates mammary tumor growth upon exosomal release.

Authors:  Virginia Egea; Kai Kessenbrock; Devon Lawson; Alexander Bartelt; Christian Weber; Christian Ries
Journal:  Cell Death Dis       Date:  2021-05-20       Impact factor: 8.469

8.  Mechanical loading attenuates breast cancer-associated bone metastasis in obese mice by regulating the bone marrow microenvironment.

Authors:  Menglu Huang; Hong Liu; Lei Zhu; Xinle Li; Jie Li; Shuang Yang; Daquan Liu; Xiaomeng Song; Hiroki Yokota; Ping Zhang
Journal:  J Cell Physiol       Date:  2021-02-07       Impact factor: 6.513

Review 9.  Importance of the origin of mesenchymal (stem) stromal cells in cancer biology: "alliance" or "war" in intercellular signals.

Authors:  Noemi Eiro; Maria Fraile; Silvia Fernández-Francos; Rosario Sánchez; Luis A Costa; Francisco J Vizoso
Journal:  Cell Biosci       Date:  2021-06-10       Impact factor: 7.133

Review 10.  Adult Stem Cell-Derived Extracellular Vesicles in Cancer Treatment: Opportunities and Challenges.

Authors:  Vadims Parfejevs; Krizia Sagini; Arturs Buss; Kristine Sobolevska; Alicia Llorente; Una Riekstina; Arturs Abols
Journal:  Cells       Date:  2020-05-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.